Financial Performance - Total revenue for 2025 reached RMB 464,822.77 million, a year-on-year increase of 36.46%[4] - Net profit attributable to shareholders of the parent company was RMB 108,552.74 million, up 6.07% compared to the previous year[4] - The company achieved a profit margin of 25.5% for the reporting period, reflecting strong operational efficiency[6] - Basic earnings per share improved to RMB 3.08, reflecting a 5.84% increase year-on-year[4] Assets and Equity - Total assets increased to RMB 1,314,380.89 million, representing an 11.85% growth from the beginning of the period[4] - Shareholders' equity attributable to the parent company rose to RMB 746,029.60 million, a 15.25% increase[4] - The company's stock capital increased by 49.39% due to capital reserve conversion and stock incentive plans[7] Market Position and Growth - The company maintained a competitive edge in the CMP equipment sector, with significant growth in ion implantation and grinding equipment shipments[6] - The company successfully expanded its customer base and entered new markets, significantly supporting revenue growth[6] Research and Development - Research and development investments were intensified, contributing to enhanced product technology and performance[6]
华海清科(688120) - 2025 Q4 - 年度业绩